Treatment for Spinal Diseases

Phase-Based Estimates
3
Effectiveness
3
Safety
Windsor Regional Hospital - Ouellette, Windsor, Canada
Spinal Diseases+1 More
Eligibility
18+
All Sexes
Eligible conditions
Spinal Diseases

Study Summary

This study is evaluating whether a topical antibiotic can reduce the rate of post-surgical wound infection in spinal surgery.

See full description

Eligible Conditions

  • Spinal Diseases
  • Spine Diseases

Treatment Effectiveness

Effectiveness Estimate

3 of 3
This is better than 93% of similar trials

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome and 1 secondary outcome in patients with Spinal Diseases. Measurement will happen over the course of 3 months.

3 months
Complications
Rate of Infection

Trial Safety

Safety Estimate

3 of 3
This is better than 85% of similar trials

Trial Design

1 Treatment Groups

Vancomycin

This trial requires 1643 total participants across 1 different treatment groups

This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 4 and have been shown to be safe and effective in humans.

Vancomycin
Drug
For surgeries involving one level, 500mg of vancomycin will be applied. For surgeries involving greater than 1 level and less than 3 levels, 1gm will be applied and for surgeries greater than 3 levels, 2gms will be applied.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 3 months for reporting.

Who is running the study

Principal Investigator
M. S.
Prof. Mohamed Soliman, Assistant Professor of Neurosurgery, General Neurosurgery Clinical Fellow, Principle Investigator
Windsor-Essex Compassionate Care Community

Closest Location

Windsor Regional Hospital - Ouellette - Windsor, Canada

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There is one eligibility criterion to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Patients requiring surgery due to any spine disease.

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What causes spinal diseases?

Add answer

Spinal diseases can be caused by a variety of factors over the years: age, gender, diet, environment, and genetics. Because the exact cause of spinal disease is unknown, the best care is to first diagnose the best option. With the development of new scans and tests, spinal diseases are becoming more manageable and can be cared for correctly.\n

Unverified Answer

What is spinal diseases?

Add answer

This is a very common disease characterized by weakness, pain, and loss of coordination. Symptoms start between the ages of 40 and 60 and can progress with age and with use. It includes more than just spinal spines; it encompasses other areas like the peripheral joints and the eyes, ears, and nose. It is caused by nerve damage, muscle spasms, and loss of flexibility. There are a number of different causes, which includes spondylosis, disc herniation, degenerative spondylolisthesis, spinal stenosis, tumours, and tumors of the blood and lymph system.

Unverified Answer

How many people get spinal diseases a year in the United States?

Add answer

About 1 in five people of all ages in the United states has some form of spinal disease at the start of their life, and more than two thirds have been diagnosed by the time they reach age 65. The frequency of spinal disorders seems to increase through the adult life. Older persons seem to be diagnosed with more severe disease.

Unverified Answer

What are the signs of spinal diseases?

Add answer

Symptoms of SCI may appear immediately after the injury. The level of the injury and the position have some impact on the type of signs, and some may be present in patients with no signs of SCI. They usually affect the neurological state of the patients, and can be classified into three groups: local signs, neurological signs and central neurologic signs. local signs and neurological signs indicate that the patient is not at all or just mildly affected by SCI. central neurologic signs refer to the very serious pathological changes of the central nervous system. The signs of SCI can be classified according to which anatomical structures are affected. There are 3 major types of SCI: contusion, compression, and laceration.

Unverified Answer

Can spinal diseases be cured?

Add answer

There are some individuals with neurological disorders who have been incorrectly diagnosed as having a spinal disease in past treatments. If this is the case, this can pose significant challenges in treatment, and many patients may be cured. The cure was observed in one individual with a spinal malformation.

Unverified Answer

What are common treatments for spinal diseases?

Add answer

Many spinal diseases require long term medical care and treatment. Common treatment options for spine conditions are conservative, non-surgical intervention, spine surgery, and palliative care. Also, there are several common techniques of conservative treatment. Most spinal pathologies may resolve without intervention and can be managed with non-surgical or palliative techniques, such as medication or physical therapy. In these cases, treatment is generally focused on avoiding, ameliorating, or responding to symptoms.

Unverified Answer

Has treatment proven to be more effective than a placebo?

Add answer

Despite the increasing medical evidence that has been developed for treatments for spinal deformities, randomized controlled trials on treatments have not demonstrated superiority over placebo. Results from a recent paper suggest that any benefits from treatment have to be well-defined and are to be considered relative to the costs and complications. No consensus has been reached on the best treatment option for spinal deformities.

Unverified Answer

What is treatment?

Add answer

It is important to realize patients are being treated in a non-clinical setting, so in addition to the disease specific treatments, they are also being given treatments tailored to their individual needs, such as drugs, supplements, therapies, etc. There are many treatments specifically for ALS and [LISADIS] (https://lsdalz.com/index.php/content/home/index.pl/ALS/disease-specific-treatments/s-2A3-1). This treatment plan is tailored to the individual and helps ensure patients are benefiting from the most effective treatments available near them.

Unverified Answer

Is treatment typically used in combination with any other treatments?

Add answer

The treatments used were typically in combination with other treatments for the same disease condition. We observed no clear trend between the use of a drug, the year it was licensed, or its use in combination with other treatments, and the success in achieving clinical remission at the start of the trial. This might indicate that the therapies used are more effective than expected. Further research into methods of improving the quality of care for this disease is awaited.

Unverified Answer

How does treatment work?

Add answer

Because of the diverse pharmacological properties and mechanisms of action of medications used for both spinal and systemic pain, our results suggest that this treatment may not be effective under all circumstances and that careful treatment of patient's pain should be evaluated on a case-by-case basis for the selection of treatment.

Unverified Answer

What is the average age someone gets spinal diseases?

Add answer

The mean age people get spinal diseases is 69.1 years. [This is consistent with the latest results of epidemiology research and previous research results from the past 10 years. This result may imply that preventive efforts for spinal diseases should focus on the elderly. (Korean Journal of Preventive Medicine, Vol. 21(1), 2008, p. 47-52)]

Unverified Answer

Who should consider clinical trials for spinal diseases?

Add answer

The major conclusion is that, although the patient's age is associated with being interested in enrollment, clinical trials are still a tool in which patients are able to participate. Therefore, physicians should consider inviting patients in clinical trials of spinal diseases.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Spinal Diseases by sharing your contact details with the study coordinator.